🧫

Gandouling protection against brain injury in Wilson's disease via SIRT1/FoxO3

active
experiment Created: 2026-04-10T22:43:37 By: experiment_extractor Quality: 90% ✓ SciDEX ID: experiment-exp-9f358501-0c3d-417e-9b43-1
🧫 Experiment Protocol Animal Modelproposed
Related Entities
SIRT1, FoxO3, GPX4, SLC7A11, ACSL4, FTH1, P53
Metadata
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T22:43:37.741195'}
p_valueNone
protocolTX mice randomly divided into 6 groups: model control, Gandouling, resveratrol, Gandouling+resveratrol, EX-527, and Gandouling+EX-527. DL mice served as blank controls. 4-week treatment intervention f
effect_sizeNone
sample_sizeNone
source_pmid41946579
extracted_at2026-04-10T15:43:37.738619
_schema_version1
experiment_typeanimal_model
success_criteriaImproved performance in behavioral tests, reduced apoptosis and oxidative stress markers, and favorable modulation of SIRT1/FoxO3 pathway proteins compared to model controls
expected_outcomesGandouling treatment would improve neurological function, reduce neuronal apoptosis, decrease oxidative stress markers, and modulate SIRT1/FoxO3 pathway expression to inhibit ferroptosis
statistical_methodsNone
📊 Evidence Profile Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
321
Outgoing
23
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.